Comparison of Minimal Versus Conventional Extracorporeal Circulation in Coronary Surgery

Sponsor
AHEPA University Hospital (Other)
Overall Status
Completed
CT.gov ID
NCT01603589
Collaborator
(none)
150
1
2
143
1

Study Details

Study Description

Brief Summary

The aim of this study is to assess the effect of minimal (MiECC) versus conventional (CECC) extracorporeal circulation on perfusion characteristics and remote end-organ protection (lungs, brain, kidneys, liver, stomach, intestine), after elective coronary bypass grafting (CABG).

Condition or Disease Intervention/Treatment Phase
  • Procedure: Coronary artery bypass grafting with the use of minimal invasive extracorporeal circulation
  • Procedure: Coronary artery bypass grafting under conventional extracorporeal circulation
N/A

Detailed Description

The aim of this study is to investigate whether coronary surgery with minimal Invasive Extracorporeal Circulation (MiECC) offers advantage over conventional CPB (CECC). In order to draw an evidence-based conclusion, the investigators aim to evaluate perfusion characteristics during coronary surgery with MECC and associated remote end-organ function. Improved end-organ protection translates into improved clinical outcome which greatly affects quality of life. This is the first study in the literature adequately powered to analyse organ pathophysiology during surgery with MECC and at the same time correlating common clinical variables with a detailed quality of life evaluation. Superiority of MECC could provide firm evidence towards widespread use of MECC in coronary surgery as standard of care.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
150 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Double (Participant, Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
Research on Remote End-organ Protection, Clinical Outcome and Quality of Life With Implementation of the Novel Minimal Extracorporeal Circulation Circuit in Open Heart Surgery
Study Start Date :
Jan 1, 2009
Actual Primary Completion Date :
Dec 1, 2020
Actual Study Completion Date :
Dec 1, 2020

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: MiECC group

Patients operated for elective coronary artery bypass grafting with the use of minimal invasive extracorporeal circulation (MiECC).

Procedure: Coronary artery bypass grafting with the use of minimal invasive extracorporeal circulation
We use a prototype AHEPA (modular type IV) circuit comprised of the standard and a standby accessory. Components of the standard circuit include: aortic cannula, three-stage venous cannula, coated tubing, a centrifugal pump, a new-generation membrane oxygenator with integrated arterial filter, a venous air removal device, a soft coated bag and pulmonary artery as well as aortic root vent. In addition, there is a standby hard-shell reservoir in parallel to the venous line, so as to convert the closed system to an open one. The standby component is bridged to the main circuit with an afferent line which is connected just before the VARD sending blood to the hard-shell reservoir and an efferent that re-directs it back to the VARD. A cell-saver device is added to the circuit for collecting shed blood and washing red blood cells for autotransfusion.

Active Comparator: CECC group

Patients operated for elective coronary artery bypass grafting under conventional extracorporeal circulation (CECC).

Procedure: Coronary artery bypass grafting under conventional extracorporeal circulation
A standard open CPB circuit is used, consisting of uncoated PVC tubing, a hard-shell venous reservoir, a microporous membrane oxygenator (Dideco, Mirandola, Italy) and a roller pump (Stöckert S3, Munich, Germany). The circuit contains a 40 μm arterial line blood filter (Dideco, Mirandola, Italy) and it is primed with 1500 mL of a balanced crystalloid/colloid solution (1000 mL of Ringer's solution, 200 mL of mannitol 20%, and 300 mL of hydroxyethyl starch 6%). Cardiotomy as well as sump sucker are integrated to the circuit.

Outcome Measures

Primary Outcome Measures

  1. Remote end-organ perfusion and function (brain, lungs, liver, kidneys, stomach, intestine) intraoperatively and postoperatively during hospital stay [30 days]

    Remote end-organ perfusion and function at 30 days follow-up after elective coronary artery bypass grafting with the use of minimal (MiECC) versus conventional (CECC) extracorporeal circulation.

Secondary Outcome Measures

  1. Postoperative major adverse cardiac and cerebrovascular events (MACCE) that comprise: myocardial infarction, low cardiac output syndrome, stroke, renal failure. [30 days]

    Postoperative major adverse cardiac and cerebrovascular events (MACCE) that comprise: myocardial infarction, low cardiac output syndrome, stroke, renal failure at 30 days follow-up after elective coronary artery bypass grafting with the use of minimal (MiECC) versus conventional (CECC) extracorporeal circulation.

  2. Duration of mechanical ventilation [30 days]

    Duration of mechanical ventilation at 30 days follow-up after elective coronary artery bypass grafting with the use of minimal (MiECC) versus conventional (CECC) extracorporeal circulation.

  3. Length of ICU stay [30 days]

    Length of ICU stay at 30 days follow-up after elective coronary artery bypass grafting with the use of minimal (MiECC) versus conventional (CECC) extracorporeal circulation.

  4. Development of new postoperative atrial fibrillation. [30 days]

    Development of new postoperative atrial fibrillation at 30 days follow-up after elective coronary artery bypass grafting with the use of minimal (MiECC) versus conventional (CECC) extracorporeal circulation.

  5. Neurocognitive function [6 months postoperatively]

    Neurocognitive evaluation with a battery of specialized tests performed by a dedicated and experienced team in clinical psychology. Evaluation will be performed at specific time intervals: preoperatively, at 1-, 3- and 6-month follow-up.

  6. Health-related quality of life [6 months postoperatively]

    Change in quality of life assessed with SF-36 questionnaire after coronary artery bypass grafting with minimal versus conventional extracorporeal circulation.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 80 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • All patients scheduled for elective coronary artery bypass grafting
Exclusion Criteria:
  • history of psychiatric disorder

  • inability to undergo neuropsychological assessment

  • history of transient ischemic attack or stroke

  • carotid artery stenosis > 60% assessed by duplex ultrasonography

Contacts and Locations

Locations

Site City State Country Postal Code
1 Cardiothoracic Department, AHEPA University Hospital Thessaloniki Greece

Sponsors and Collaborators

  • AHEPA University Hospital

Investigators

  • Principal Investigator: Kyriakos Anastasiadis, MD, PhD, FETCS, Cardiothoracic Department, AHEPA University Hospital, Thessaloniki, Greece

Study Documents (Full-Text)

None provided.

More Information

Additional Information:

Publications

Responsible Party:
Kyriakos Anastasiadis, Professor, AHEPA University Hospital
ClinicalTrials.gov Identifier:
NCT01603589
Other Study ID Numbers:
  • AHEPA_CTS_04
First Posted:
May 22, 2012
Last Update Posted:
Jan 12, 2021
Last Verified:
Jan 1, 2021
Keywords provided by Kyriakos Anastasiadis, Professor, AHEPA University Hospital

Study Results

No Results Posted as of Jan 12, 2021